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Phytotherapy Research. 2019;1–8.Diabetes is a metabolic disease highly widespread worldwide, and the most common
form is the type 2 diabetes mellitus (T2DM). A large number of synthetic drugs are cur-
rently available for the treatment of diabetes; however, they present various side
effects and, for this reason, people are increasingly inclined to search natural alternative
treatments. Among these, Arctium lappa (A. lappa) has interesting anti‐diabetic activi-
ties, exerted by improving glucose homeostasis and reducing insulin‐resistance. In addi-
tion, A. lappa exerts a marked antioxidant activity, an effect known to play a pivotal role
in the treatment of T2DM. The purpose of this review is to analyse scientific evidence in
order to evaluate the role of A. lappa and its bioactive compounds in management of
T2DM. The literature search performed provided only in vitro and animal‐based stud-
ies. No clinical studies have been conducted in order to investigate the effect ofA. lappa
onT2DM patients. However, available literature provides evidence for further clinical
trials in order to confirm these claimed activities on humans.
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Type 2 diabetes mellitus (T2DM) is a metabolic disease that affects a
large number of people in the world, and it is therefore considered
an epidemic (Aschner, 2017). T2DM is characterized by decreased
β‐cells insulin secretion ability and/or insulin‐resistance, resulting in, 5′ adenosine monophosphate‐activa
lase‐1; GLUT, glucose transporter; ARE
globin; GLP‐1, glucagon‐like peptide;
nts; DCM, dichloromethane; EtOH, eth
, superoxide dismutase; GHS‐Px, gluta
wileyonlinelibrary.com/jchronically elevated blood glucose levels (American Diabetes
Association, A.D.A, 2014; American Diabetes Association, A.D.A,
2017). Persistent hyperglycaemia is recognized as one of the main
causes of oxidative stress, which drastically impairs biologically struc-
tures, causing several T2DM complications (Aronson, 2008; Baynes
& Thorpe, 1999; Ceriello, 2000; Maritim, Sanders & Watkins, 2003).ted protein kinase; GPAT, glycerol‐3‐phosphate acyltransferase; HMGCR, 3‐hydroxy‐3‐
, A. lappa root extract; HOMA‐IR, homeostasis model assessment–insulin resistance; HFD,
TAS2R, taste receptor type 2; ROS, reactive oxygen species; ABTS, 2,2′‐azino‐bis(3‐
anol; DPPH, 2,2‐diphenyl‐1‐picrylhydrazyl; FRAP, ferric reducing antioxidant power; MeOH,
thione peroxidase; CAT, catalase; MDA, malondialdehyde; TAOC, total antioxidant capacity;
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TABLE 1 In vitro and in vivo studies demonstrating the anti‐diabetic effect of A. lappa
Authors Type of study Experimental model Extract/compound Observed effect
Tousch et al.
(2014)
In vitro L6 myocytes Arctium lappa root
extract rich in
caffeoylquinic acid
derivatives
Increased glucose
uptake
Hepatocytes from rats A. lappa root extract rich
in caffeoylquinic acid
derivatives
Reduced glucose
output induced by
glucagon
In vivo Mice Intraperitoneal and oral
administration of
dried Arctium lappa
root extract rich in
caffeoylquinic acid
derivatives
Improvement in oral
glucose tolerance
Tang et al.
(2011)
In vitro H9C2 and C2C12 cell
line
Arctigenin Promotion of AMPK
phosphorylation
Franco et al.
(2018)
In vitro Inhibition assay A. lappa ethanol and
hexane extracts
Inhibition of α‐
glucosidase activity
Kuo et al.
(2012)
In vitro HepG2 cells A. lappa n‐hexane
extract
Activation of AMPK
Xu et al.
(2008)
In vivo Alloxan‐induced
diabetic mice
Total lignans from
Fructus arctii (2.0, 1.0,
and 0.5 g/kg) for
10 days
Decreased blood
glucose levels;
increased plasma
levels of insulin
Xu et al.
(2014)
In vivo Goto‐Kakizaki type 2
diabetic mice
Total lignans from
Fructus arctii
(300 mg/kg) for
12 weeks
Decreased blood
glucose levels and
HbA1c;
improvement in
glucose tolerance;
insulin and GLP‐1
release stimulation
Xu et al.
(2015)
In vivo Goto‐Kakizaki type 2
diabetic mice
Arctigenic acid (50 mg/
kg) for 12 weeks
Decreased FBG and
HbA1c;
improvement in oral
glucose tolerance
Ahangarpour
et al.
(2017)
In vivo Diabetic mice model A. lappa hydro‐alcoholic
extract (200 and
300 mg/kg) for
28 days
Reduced glycaemia
(p < .001 for both
200 and 300‐mg
extract); increased
insulinemia (p < .05
for 200‐mg extract);
improved HOMA‐IR
(p < .05 for 300‐mg
extract)
Bok et al.
(2017)
In vivo Mice A. lappa water extract
(50 mg/kg/day and
250 mg/kg/day) for
8 weeks
Decreased HFD‐
induced weight gain
and blood glucose
levels
Gao et al.
(2018)
In vivo KKAy type 2 diabetic
and obese mice
Total lignans from
Fructus arctii (250
and 125 mg/kg) for
11 weeks
Decreased FBG,
HbA1c and body
weight;
improvement in oral
glucose tolerance;
increased insulin
secretion
Abbreviations: AMPK: 5′ adenosine monophosphate‐activated protein kinase; FBG: fasting blood glucose; GLP‐1: glucagon‐like peptide‐1; HbA1c: glycated
haemoglobin; HFD, high‐fat diet; HOMA‐IR, homeostasis model assessment–insulin resistance.
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ment of diabetes; however, they present various side effects and, for
this reason, people are increasingly inclined to search natural alterna-
tive treatments (Ota & Ulrih, 2017). Among these, A. lappa could be
considered a good candidate as natural treatment for the management
of T2DM.
Arctium lappa L. (A. lappa), also known as burdock, bardana, or
Fructus arctii, is an herbaceous plant belonging to the Asteraceae
botanical family, very popular in Asia as food and medical plant. The
plant can grow up to a height of 1 m; it has large leaves and spherical
inflorescences, of purple colour. Seeds are oval and covered with yel-
low hair. In China, A. lappa is also known as “Niubang” and its use has
largely been applied in traditional Chinese medicine treatments for
over 3,000 years (Chan et al., 2011). In Ppytotherapy, dried root,
leaves, fruits, and seeds from A. lappa are used (Chan et al., 2011).
Each part of the plant has a different composition, especially in terms
of biologically active compounds; indeed, a large variety of bioactive
compounds are contained in the phytocomplex, such as terpenoids
(beta‐eudesmol, C15H24O, present in fruits), sterols (sitosterol‐beta‐
D‐glucopyranoside, C35H60O6, contained in roots), lignans, polyphe-
nols, and fructans (Chan et al., 2011). Generally, A. lappa is a safe plant.
Only minimal side effects, such as dermatitis or urticaria, have been
reported (Chan et al., 2011). Toxicity studies conducted on mice have
demonstrated the absence of adverse effects with <250 mg/kg A.
lappa water extract administration for 8 weeks (Bok et al., 2017);
moreover, administration of 280 mg/kg arctigenin, one of the main
component of A. lappa, for 2 weeks, does not cause side effects (Xu
et al., 2015).
Arctium lappa beneficial properties are rather known; indeed, anti-
oxidant, antiinflammatory, and anticancer (Chan et al., 2011) activities
have been attributed to the plant. Not recently, however, studies pro-
vided evidence about the anti‐diabetic activity of A. lappa. In tradi-
tional Chinese medicine, A. lappa is largely used as anti‐diabetic
natural remedy (Chan et al., 2011). Xiao‐Ke tea is one of the traditional
phytotherapic remedy used in China for treatment of T2DM, in which
A. lappa is the main component (Hale et al., 1989).
In this paper, by the analysis of current scientific evidence we
sought to evaluate the role of A. lappa in the management of T2DM
and its complications, such as oxidative stress. Particularly, a literature
search has been conducted in official scientific databases, including
PubMed (http://www.ncbi.nlm.nih.gov/pubmed) and Science Direct
(http://www.sciencedirect.com). Articles in English were identified
using specific keywords (“Arctium lappa,” “Burdock,” “Fructus arctii,”
“type 2 diabetes mellitus,” “hyperglycaemia,” “oxidative stress,” and
“antioxidant activity”) and their combinations.2 | ANTI‐DIABETIC EFFECTS OF A. LAPPA :
SCIENTIFIC EVIDENCE
There is scarce evidence about the anti‐diabetic effect of A. lappa. The
literature search only provided four in vitro studies and seven in vivo
studies, as summarized in Table 1; these latter were all conducted onanimal‐based model. No clinical studies were found; however, all avail-
able evidence is concordant.2.1 | In vitro studies
The main bioactive compound with anti‐diabetic activity is sitosteol‐
beta‐D‐glucopyranoside, which acts by inhibiting α‐glucosidase (Chan
et al., 2011), an enzyme involved in hydrolysis of glycogen, leading to
the release of single units of glucose. The inhibition of α‐glucosidase
activities is considered an efficacious strategy for the management
of T2DM, and it is exerted by several phytochemicals (Shori, 2015).
Franco et al. (2018) demonstrated that A. lappa ethanol and hexane
extracts exerted an α‐glucosidase inhibitory activity (20.8 ± 0.4%
and 25.1 ± 1.1%, respectively).
Among the molecular targets for the management of T2DM, stim-
ulation of the 5′ adenosine monophosphate‐activated protein kinase
(AMPK) is one of the most important. AMPK inhibits specific enzymes
involved in anabolic processes, such as glycerol‐3‐phosphate
acyltransferase, in triacylglycerols synthesis; 3‐hydroxy‐3‐
methylglutarul‐CoA reductase (HMGCR), in sterols synthesis and
acetyl‐CoA carboxylase 1 (ACC1), in fatty acid synthesis; on the other
hand, it improves glucose uptake by stimulating glucose transporter
(GLUT)‐1 action and GLUT4 translocation on muscle cell membranes
(Mihaylova & Shaw, 2011). It has been demonstrated that arctigenin
is able to promote the AMPK phosphorylation in H9C2 and C2C12
cell lines by Ca2+/calmodulin‐dependent protein kinase kinase and
liver kinase B 1‐dependent pathways (Tang et al., 2011). The same
result in activation of AMPK has been also found by Kuo et al.
(2012) in HepG2 cells treated with A. lappa n‐hexane fraction.
The anti‐hyperglycaemic activity of an A. lappa root extract (ARE)
rich in caffeoylquinic acid derivatives was tested on L6 myocytes
and rat‐derived hepatic cell lines. In particular, in muscle cells ARE
increased the uptake of glucose, and in hepatocytes it reduced the
output of glucose induced by glucagon (Tousch et al., 2014).2.2 | In vivo studies
Several studies investigated the effects of A. lappa extract or its bioac-
tive components in improving glycaemic homeostasis in murine
models. In this context, recently, two animal‐based studies showed
the effect of A. lappa hydro‐alcoholic (Ahangarpour et al., 2017) and
water (Bok et al., 2017) extract. In the first one, 200 and 300 mg/kg
of hydro‐alcoholic extract were administered to diabetic mice for
28 days. After the treatment period, reduced glycaemia (p < .001 for
both 200 and 300 mg/kg of extract), increased insulinemia (p < .05
for 200 mg/kg extract) and improved insulin‐resistance, evaluated by
using the Homeostasis Model Assessment–Insulin Resistance
(HOMA‐IR; p < .05 for 300 mg/kg extract) were found. The authors
explained these anti‐diabetic effects by amelioration of β‐cell function,
stimulation of insulin secretion, reduction of insulin resistance, and
reduction of glucose intestinal absorption (Ahangarpour et al., 2017).
In the other study, 8‐week administration of A. lappa water extract
4 ANNUNZIATA ET AL.at two dosages (50 and 250 mg/kg/day) significantly decreased high‐
fat diet‐induced weight gain and blood glucose levels (Bok et al.,
2017). In addition, ARE rich in caffeoylquinic acid derivatives exerts
anti‐hyperglycaemic effect, both after acute (intraperitoneal) and sub-
chronic (oral) administration (Tousch et al., 2014).
Total lignans (TL) from A. lappa dried fruits, obtained by an ethanol
extraction, improved glucose homeostasis in alloxan‐induced diabetic
mice (Xu et al., 2008). In particular, three different dosages (0.5, 1.0,
and 2.0 g/kg) were administered for 10 days, and glucose and insulin
blood levels were monitored. In diabetic mice, but not in normal mice
(control group), decreased blood glucose levels and increased plasma
insulin levels were found, with a dose‐dependent relationship (Xu
et al., 2008). Similarly, Xu, Ju, Wang, Gu, and Feng (2014) showed that
administration of TL (300 mg/kg twice daily before each meal) in dia-
betic animal model (Goto‐Kakizaki rats), for 12 weeks, induced a sig-
nificant amelioration in glycaemic profile by reducing both blood
glucose levels and glycated haemoglobin (HbA1c) and by improving
oral glucose tolerance. In addition, authors also found increased insulin
secretion and glucagon‐like peptide (GLP)‐1 release (Xu et al., 2014).
Although the authors did not stress this aspect, it worth noting that
an increase in GLP‐1 release has been reported to be an efficacious
therapeutic strategy for the management of T2DM (Ezcurra, Reimann,
Gribble & Emery, 2013; Troke, Tan & Bloom, 2014). This action might
be also considered for medical plants and certain foods. In particular, a
recent narrative review highlights the effects of natural bitter com-
pounds in stimulating intestinal bitter taste receptors (taste receptor
type 2, TAS2R), resulting in increased incretine release, including
GLP‐1 (Barrea et al., 2019). Potentially, thus, the increased GLP‐1
release observed by Xu and colleagues could be explained by an inter-
action of these compounds with TAS2R; however, further studies are
needed.
The anti‐diabetic activity of TL from A. lappa dried fruit was also
recently investigated by Gao and colleagues (2018). Diabetic and
obese mice (KKAy rodent model) were treated for 11 weeks with
125 and 250 mg/kg TL. After the treatment period, authors found a
statistically significant reduction of fasting glycaemia, HbA1c, and
body weight and improved oral glucose tolerance. In addition, a stim-
ulatory effect was observed on several pathways, including phos-
phatidylinositol 3 kinase/protein kinase B and AMPK (Gao et al.,
2018). Among the lignans, arctigenin is considered one of the most
important compounds of A. lappa extract showing hypoglycaemic
activity. In particular, Xu et al. (2015) showed that oral administration
of arctigenic acid (50 mg/kg, twice daily for 12 week) in Goto‐Kakizaki
rats reduced blood glucose and HbA1c levels, by stimulating insulin
secretion.
In summary although limited as number, all experimental studies
available, both in vitro and in vivo, are strongly suggestive of the high
potential of A.lappa components as antidiabetic remedies. Results
obtained in vitro, on cell cultures, have found confirmation in vivo, in
different animal models of diabetes. Unfortunately, to date, there are
no clinical studies available; nonetheless, encouraging results
obtained from experimental studies open the way for future clinical
studies.3 | THE ROLE OF A. LAPPA IN
CONTRASTING THE OXIDATIVE STRESS
Oxidative stress is a pathological condition due to an imbalance
between production and elimination of oxidants, such as reactive oxy-
gen species (ROS) and reactive nitrogen species (Johansen, Harris,
Rychly, & Ergul, 2005; Limon‐Pacheco & Gonsebatt, 2009; Valko
et al., 2007). Physiologically, ROS and reactive nitrogen species are
produced in small amounts, because endogenous antioxidant systems
are able to contrast their actions. On the other hand, elevated
amounts of free radicals cause the oxidation of lipids, proteins,
and nucleic acids, thereby producing toxic molecules and
causing DNA damages (Limon‐Pacheco & Gonsebatt, 2009; Valko
et al., 2007).
There is evidence that in diabetic subjects the hyperglycaemia is the
main cause of oxidative stress (Esposito et al., 2002; Ganjifrockwala,
Joseph & George, 2017). In particular, chronic hyperglycaemia is impli-
cated in mechanisms that are considered to be the cause of oxidative
stress, including glucose auto‐oxidation, increased protein glycation,
intensified glucose input into the polyol pathway, and advanced
glycosilation end product formation (Aronson, 2008; Baynes & Thorpe,
1999; Ceriello, 2000; Maritim, Sanders & Watkins, 2003). Therefore,
nutraceuticals or dietary sources of antioxidant may represent a useful
natural approach for the management of T2DM. In this contest, the
nutraceutical potential of A. lappa appears prominent considering that
in addition to the aforementioned anti‐diabetic effect, this medical
plant also exerts a marked antioxidant activity.
Several studies investigated the antioxidant activity of A. lappa. As
summarized inTable 2, however, different assays were performed, and
for the same assay, the results were expressed in different ways. In
addition, different plant parts were used and various extraction
methods were performed. Thus, the comprehension of the A. lappa
antioxidant and antiradical potential might not be easy and direct for
nontechnicians.
Ferracane, Graziani, Gallo, Fogliano, and Ritieni (2010) evaluated
the radical scavenging activity of different A. lappa plant parts by using
the 2,2′‐azino‐bis(3‐ethylbenzothiazoline‐6‐sulphonic) acid (ABTS)
assay; they found that the antioxidant activity ranged from 0.0016
to 0.0289 mmol Trolox equivalent (TE) per 100 g dry weight in roots
and leaves, respectively.
Themajority of available studies exploring the antioxidant activity of
A. lappa were conducted on extracts from roots, with different extrac-
tion methods. Predes, Ruiz, Carvalho, Foglio, and Dolder (2011) tested
the antioxidant activity of (a) dichloromethane (DCM), ethanol (EtOH),
and water (plant/solvent, 1:2); (b) DCM, EtOH, and water (plant/sol-
vent, 1:5); (c) water (plant/solvent, 1:5); and (d) 70% EtOH (plant/sol-
vent, 1:5) extracts, by using 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH)
assay. Among these, only the 70% EtOH extract showed a marked anti-
radical activity. In particular, EtOH extract EC50 was 4.79 ± 0.15 μg/ml
comparedwithTrolox (1.13 ± 0.1 μg/ml). EC50 is the antioxidant amount
needed to reduce the concentration of DPPH by 50%. In addition, the
time necessary to reach the EC50 (TEC50) was 5 and 0.1 min for EtOH
extract and Trolox, respectively, and the antiradical efficiency (AE),
ANNUNZIATA ET AL. 5calculated as follow: AE = 1/(EC50 × TEC50), was 0.0418 ± 0.001 (EtOH
extract) and 8.98 ± 0.84 (Trolox; Predes et al., 2011). Similar resultswere
found in other studies in which root hydro‐EtOH extractions were per-
formed, although in different proportions. In particular, thewater/EtOH
(1:1, v/v) extract antioxidant activity assessed by DPPH andTABLE 2 In vitro studies exploring the antioxidant activity of A. lappa
Authors Part of plant Extraction metho
Ferracane et al. (2010) Roots and
leaves
Extraction with 7
methanol by RT
sonication
Predes et al. (2011) Roots 70% ethanol
extraction (1:5,
plant solvent)
Li et al. (2013) Whole plant Boiling water
extraction
Takebayashi et al.
(2013)
Roots Hexane/
dichloromethan
(1:1) followed b
methanol/wate
acetic acid
(99:9.5:0.5)
Liu et al. (2014) Roots Hot water extrac
Jiang et al. (2016) Roots 55% ethanol
extraction
Jimenez‐Zamora,
Delgado‐Andrade
and Rufian‐Henares
(2016)
N.D. Boiling water
extraction by
infusion for 7 m
Fierascu et al. (2018) Roots Water‐ethanol (1
extraction
Franco et al. (2018) Leaves Ethanol (Et) or
hexane (Hex) st
maceration for
seven days
Rodriguez et al. (2018) Roots scCO2 as solvent
methanol as co
solvent
Abbreviations: ABTS, 2,2′‐azino‐bis(3‐ethylbenzothiazoline‐6‐sulphonic) acid;
antioxidant amount needed to reduce the concentration of DPPH by 50%; FR
capacity; scCO2: supercritical CO2 RT: room temperature; TE, Trolox equivalenphosphomolybdate method was 76.23 ± 0.29% and, respectively,
269.5 mg/g ascorbic acid equivalent (Fierascu et al., 2018).
In 2016, Jang and colleagues performed an A. lappa root hydro‐
EtOH extraction under reflux, isolating eight different caffeoylquinic
acid derivatives. The antioxidant activity of these compounds rangedd Antioxidant assay Results
0% ABTS (mmol TE per
100 g)
0.0016 (roots)
0.0289 (leaves)
DPPH (EC50, μg/ml;
TEC50, min; AE)
EC50: 4.79 ± 0.15;
TEC50: 5; AE:
0.0418 ± 0.001
FRAP (μmol Fe (II) per g) 207.71 ± 19.86
ABTS (μmol TE per g) 167.89 ± 18.78
e
y
r/
ORAC (μmol TE per g) 66.07 ± 12.74
DPPH (μmol TE per g) 19.37 ± 19.37
tion Hydroxyl radical
scavenging assay (%)
At 2.5 mg/ml
extract = 99.19%
ABTS (%) At 5.5 mg/ml
extract = 72.5%
Chelating ability on
ferrous ions (%)
At 1.25–5.0 mg/ml
extract = nearly
100%
DPPH (mM) Min.: 9.210 ± 3.840;
max: 46.362 ± 3.992
ABTS (mM) Min.: 1.130 ± 0.183;
max: 1.187 ± 0.008
FRAP (mM of FeSO4
equivalents)
Min.: 3.810 ± 1.013;
max: 6.792 ± 1.749
in
ABTS (mmol TE per L) 1.06 ± 0.00
DPPH (mmol TE per L) 1.26 ± 0.02
FRAP (mmol TE per L) 1.00 ± 0.11
:1) DPPH (% antioxidant
potential)
76.26 ± 0.29
Phosphomolybdate
method (total
antioxidant capacity
expressed as mg of
ascorbic acid
equivalent)
269.5
atic
FRAP (μmol TE per g) Et: 58.7 ± 1.2; Hex:
15.2 ± 2.2
DPPH (%) Et: 72.8 ± 1.2; Hex:
22.8 ± 7.3
ORAC (μmol TE per g) Et: 926.9 ± 48.3; Hex:
867.9 ± 36.6
and
‐
DPPH (IC50) IC50 = 0.13 mg extract
per ml
AE: antiradical efficiency; DPPH, 2,2‐diphenyl‐1‐picrylhydrazyl; EC50: the
AP: Ferric Reducing Antioxidant Power; ORAC: oxygen radical absorbance
ts; TEC50: the time necessary to reach the EC50.
FIGURE 1 Mechanisms of action by which A. lappa could contribute to the management of Type 2 diabetes mellitus (T2DM). AMPK: 5′
adenosine monophosphate‐activated protein kinase; GLP‐1, glucagon‐like peptide; HbA1c, glycated haemoglobin [Colour figure can be viewed
at wileyonlinelibrary.com]
6 ANNUNZIATA ET AL.from 9.210 ± 3.840 to 46.362 ± 3.992 mM (DPPH assay),
1.130 ± 0.183 to 1.187 ± 0.008 mM (ABTS assay), and
3.810 ± 1.013 to 6.792 ± 1.749 mM FeSO4 equivalents (Ferric Reduc-
ing Antioxidant Power, FRAP assay).
Extraction methods using hexane as part of the mixture were also
performed. In particular, a hexane/DCM (1:1) extraction followed by a
methanol (MeOH)/water/acetic acid (95:9.5:0.5) extraction was per-
formed on A. lappa root. The antioxidant activity evaluated by using
DPPH and oxygen radical absorbance capacity (ORAC) assays was
19.37 and 66.07 μmol TE per g, respectively (Takebayashi et al.,
2013). Franco et al. (2018) evaluated the antioxidant activity of EtOH
and hexane (Hex) extracts of leaves from A. lappa, obtained by a 7‐day
static maceration. The two extracts showed different antioxidant
capacity evaluated by FRAP (15.2 ± 2.2 and 58.7 ± 1.2 μmol TE per
g, for Hex and EtOH extract, respectively), DPPH (22.8 ± 7.3 and
72.8 ± 1.2%, for Hex and EtOH extract, respectively), and ORAC
(867.9 ± 36.6 and 926.9 ± 48.3 μmol TE per g, for Hex and EtOH
extract, respectively; Franco et al., 2018), suggesting that EtOH is
more effective for extraction of bioactive compounds with a marked
antioxidant activity. Moreover, Rodriguez et al. (2018) demonstrated
that supercritical extraction using CO2 as solvent and MeOH as co‐
solvent is effective to obtain an extract with a high antioxidant activ-
ity, evaluated by using DPPH (IC50: 0.13 mg/ml).
Some authors evaluated the antioxidant capacity of A. lappa
extracts obtained with hot‐water extractions (Jimenez‐Zamora,
Delgado‐Andrade & Rufian‐Henares, 2016; Li et al., 2013; Liu et al.,
2014). Particularly, whole plant extract antioxidant activity was
207.71 ± 19.86 μmol Fe (II) per g (FRAP) and 167.89 ± 18.78 μmol
TE per g (ABTS; Li et al., 2013). On the other hand, antioxidant assays
were performed on water infusion, and following results, expressed as
mmol TE per l, were found: 1.00 ± 0.00 for ABTS, 1.26 ± 0.02 for DPPH
and 1.00 ± 0.11 for FRAP (Jimenez‐Zamora, Delgado‐Andrade &
Rufian‐Henares, 2016). Interestingly, Liu et al. (2014) conducted a
study using a water extract, in order to evaluate the antioxidant activity
of polysaccharides from A. lappa root. At first, the researchers evalu-
ated this activity with in vitro assays, including hydroxyl radical scav-
enging assay, ABTS, and chelating ability on ferrous ions, finding a
strong activity, particularly 99.19% (at 2.5 mg/ml, compared with
ascorbic acid), 72.5% (at 5.0 mg/ml, compared withTrolox), and nearly
100% (at 1.25–5.0 mg/ml, compared with EDTA). In addition, the samegroup conducted an in vivo study on IRCmice treated with D‐galactose
(500 mg/kg) in order to stimulate oxidative stress. Mice were treated
with three dosages of the water‐extracted polysaccharides from A.
lappa (100, 200, and 400 mg/kg) for 8 weeks. The activity of endoge-
nous defences against ROS, including superoxide dismutase (SOD), glu-
tathione peroxidase (GSH‐Px), catalase (CAT), the levels of
malondialdehyde (MDA; a marker of peroxidation), and total antioxi-
dant capacity (TAOC) were evaluated. The authors found significant
increases in SOD, GSH‐Px, CAT, and TAOC and decreased levels of
MDA (Liu et al., 2014). Similar results were found in further in vitro
studies conducted on two different cell lines (Tian et al., 2014; Wang
et al., 2007). In particular, in 3T3 cells 24‐hr treatment with
0–200 μg/ml methanol extract of A. lappa root significantly increased
the activity of GSH, GSH‐Px, glutathione reductase, glutathione trans-
ferase, and CAT, in a dose‐dependent manner (Wang et al., 2007). In
PC12 cells increased activity of GSH‐Px and SOD, and decreased levels
of MDA were found after pretreatment with a hydro‐EtOH extract of
A. lappa root, partitioned with ethyl acetate. In addition, treatment with
20, 40, and 80 μg/ml of this extract also reduced ROS accumulation in
a dose‐dependent manner (Tian et al., 2014).
In summary, there is much evidence for the antioxidant activity
of A.lappa, in particular of different extracts of plant parts, especially
roots; such an effect, might be of relevant clinical significance in the
management of T2DM, because it is widely known that persistent
hyperglycaemia causes an imbalance between oxidants and antioxi-
dants and the following diabetes‐associated organ damage. Thus,
under this aspect a nutraceutical compound that ameliorates glucose
homeostasis, by a hand, and, by the other hand, exerts antioxidant
activity might represents a valuable therapeutic approach for
diabetes.4 | CONCLUSION AND FUTURE
PROSPECTIVE
Studies available in scientific literature provide evidence of the A.
lappa beneficial effects on health. In particular, the plant appears use-
ful in the management of T2DM; thus, folk uses are strongly sup-
ported by scientific evidence. In particular, A. lappa has been shown
to improve glucose homeostasis acting with different mechanisms,
ANNUNZIATA ET AL. 7including (a) increased glucose uptake in muscle, (b) reduced glucose
output induced by glucagon in hepatocytes, (c) activation of AMPK
pathways, (d) inhibition of α‐glucosidase activity, and (d) stimulation
of GLP‐1 release. On the other hand, this medical plant is able to
reduce insulin‐resistance by ameliorating β‐cells function and stimulat-
ing weight loss. Moreover, due to the presence of a marked polyphe-
nolic component, A. lappa has appreciable antioxidant activity,
important to contrast oxidative stress, which is a direct consequence
of T2DM (Figure 1).
However, a small number of studies are available and all evidence,
to our knowledge, is in vitro or animal‐based studies. No studies were
conducted on human. This is a weak point that could hinder the
spread of A. lappa use in clinical practice. However, available literature
provides evidence for further clinical trials in order to confirm these
claimed activities on humans. In particular, pharmacokinetics studies
and clinical randomized, placebo‐controlled studies should be con-
ducted on T2DM or prediabetic subjects, obese, or overweight, in
order to evaluate the effect of A. lappa, or its single bioactive com-
pounds, in the improvement of glycaemic profile and weight control.
Results should be adjusted for confounding variables, such as diet,
physical activity, and pharmacological treatment, in order to consider
the inclusion of A. lappa as possible natural treatment for diabetes
and its complications.
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